Table 1.
Variable | RRP (n=95) | RALP (n=140) | P-value |
---|---|---|---|
Preoperative patient data | |||
Mean follow-up (yr) | 9.4 | 4.5 | |
Mean age (yr) | 60.3 | 62.1 | 0.185 |
Preoperative Gleason score | 6.7 | 6.6 | 0.642 |
<6 | 52.6 (50) | 50 (70) | 0.845 |
7 | 26.3 (25) | 25.0 (35) | 0.765 |
>8 | 21.1 (20) | 25.0 (35) | 0.345 |
Mean preoperative PSA | 9.1 | 8.3 | 0.502 |
<10 | 81.1 (77) | 80.0 (112) | 0.876 |
10–20 | 11.6 (11) | 14.3 (20) | 0.324 |
>20 | 7.3 (7) | 5.7 (8) | 0.234 |
Clinical stage | |||
T1 | 55.8 (53) | 53.6 (75) | 0.756 |
T2 | 44.2 (42) | 46.4 (65) | 0.245 |
>T3 | 0 (0) | 0 (0) | |
Postoperative pathologic data | |||
Final Gleason score | |||
Mean | 7.2 | 7.2 | 0.893 |
<6 | 22.1 (21) | 17.1 (24) | 0.564 |
7 | 46.3 (44) | 55.7 (78) | 0.345 |
>8 | 31.6 (30) | 27.2 (38) | 0.456 |
Pathologic stage | |||
T3a | 49.5 (47) | 47.1 (66) | 0.456 |
T3b | 42.1 (40) | 45.7 (64) | 0.754 |
T4 | 8.4 (8) | 7.2 (10) | 0.652 |
Positive margin | 58.9 (56) | 47.1 (66) | 0.083 |
Biochemical recurrence | 18.9 (18) | 18.5 (26) | 0.943 |
Median biochemical recurrence free survival (mo) | 12.0 | 12.0 | 0.740 |
Values are presented as number (%).
RRP, radical retropubic prostatectomy; RALP, robotic-assisted laparoscopic prostatectomy; PSA, prostate specific antigen.